| Outcome Measures: |
Primary: Itching intensity, Numerical rating scale (NRS), 7 weeks | Secondary: Pruritus-specific quality of life (QoL), Skindex-10, 7 weeks|Pruritus-specific sleep quality, Itch MOS, 7 weeks|Assessment of depression, Beck Depression Inventory-II, 7 weeks|Patient Global Impression of Change (PGIC), 7 weeks
|
| Locations: |
Arizona Kidney Disease and Hypertension Center, Phoenix, Arizona, 85012, United States|US Renal Care, Pine Bluff, Arkansas, 71603, United States|Valley Renal Medical Group, Northridge, California, 91324, United States|North America Research Institute, San Dimas, California, 91773, United States|Pines Clinical Research, Inc., Pembroke Pines, Florida, 33028, United States|Genesis Clinical Research, Tampa, Florida, 33614, United States|Boise Kidney and Hypertension Institute, Meridian, Idaho, 83642, United States|Fresenius Medical Care of Evergreen Park, Evergreen Park, Illinois, 60805, United States|Renal Medicine Associates, Albuquerque, New Mexico, 87109, United States|US Renal Care, Gallup, New Mexico, 87313, United States|Ridgewood Dialysis Center, Ridgewood, New York, 11385, United States|Brookview Hills Research Associates LLC, Winston-Salem, North Carolina, 27103, United States|Southeast Renal Research Institute, Chattanooga, Tennessee, 37408, United States
|